Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Operating Leases (2022 - 2025)

Treace Medical Concepts (TMCI) has disclosed Operating Leases for 4 consecutive years, with $14.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases fell 12.25% year-over-year to $14.0 million, compared with a TTM value of $14.0 million through Dec 2025, down 12.25%, and an annual FY2025 reading of $14.0 million, down 12.25% over the prior year.
  • Operating Leases was $14.0 million for Q4 2025 at Treace Medical Concepts, up from $12.9 million in the prior quarter.
  • Across five years, Operating Leases topped out at $19.0 million in Q3 2022 and bottomed at $12.9 million in Q3 2025.
  • Average Operating Leases over 4 years is $15.7 million, with a median of $15.9 million recorded in 2023.
  • The sharpest move saw Operating Leases rose 4.65% in 2024, then decreased 21.57% in 2025.
  • Year by year, Operating Leases stood at $15.5 million in 2022, then rose by 2.27% to $15.9 million in 2023, then increased by 0.27% to $15.9 million in 2024, then fell by 12.25% to $14.0 million in 2025.
  • Business Quant data shows Operating Leases for TMCI at $14.0 million in Q4 2025, $12.9 million in Q3 2025, and $13.4 million in Q2 2025.